ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
Dyne Therapeutics Inc

Dyne Therapeutics Inc (DYN)

14.91
-0.63
( -4.05% )
更新日時: 00:16:07

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
14.91
買値
14.87
売値
14.94
出来高
99,271
14.76 日の範囲 15.62
14.73 52 週間の範囲 47.45
時価総額
前日終値
15.54
始値
15.60
最終取引時間
00:16:29
財務取引量
US$ 1,521,023
VWAP
15.3219
平均取引量 (3 か月)
1,228,075
発行済株式数
101,765,958
配当利回り
-
PER
-6.70
1 株当たり利益 (EPS)
-2.32
歳入
-
純利益
-235.94M

Dyne Therapeutics Inc について

Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy.

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Dyne Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker DYN. The last closing price for Dyne Therapeutics was US$15.54. Over the last year, Dyne Therapeutics shares have traded in a share price range of US$ 14.73 to US$ 47.45.

Dyne Therapeutics currently has 101,765,958 shares in issue. The market capitalisation of Dyne Therapeutics is US$1.58 billion. Dyne Therapeutics has a price to earnings ratio (PE ratio) of -6.70.

DYN 最新ニュース

Dyne Therapeutics Reports New Clinical Data Showing Compelling Impact on Multiple Measures of Myotonic Dystrophy Type 1 (DM1); Dyne Plans to Initiate Registrational Expansion Cohort to Support Potential Submission for U.S. Accelerated Approval for DYNE-101

- DYNE-101 in DM1: Dyne plans to initiate global Registrational Expansion Cohort of ACHIEVE trial with registrational dose of 6.8 mg/kg Q8W following study data showing splicing correction and...

Dyne Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

WALTHAM, Mass., Jan. 09, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage neuromuscular disease company focused on advancing innovative life-transforming...

Dyne Therapeutics to Host Investor Conference Call and Webcast to Review New Clinical Data from the ACHIEVE Trial Friday, January 10 at 8:00 a.m. ET

WALTHAM, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage neuromuscular disease company focused on advancing innovative life-transforming...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-3.68-19.795589026418.5919.77914.73458161115.60688159CS
4-9.52-38.968481375424.4326.2214.73180942919.02023936CS
12-16.29-52.211538461531.235.6814.73122807524.65330047CS
26-28.35-65.533980582543.2647.4514.73120714131.65234243CS
52-1.47-8.9743589743616.3847.4514.73126634029.67322614CS
1567.0188.73417721527.947.454.374213522.23753018CS
260-8.54-36.417910447823.4547.454.359858921.67095017CS

DYN - Frequently Asked Questions (FAQ)

What is the current Dyne Therapeutics share price?
The current share price of Dyne Therapeutics is US$ 14.91
How many Dyne Therapeutics shares are in issue?
Dyne Therapeutics has 101,765,958 shares in issue
What is the market cap of Dyne Therapeutics?
The market capitalisation of Dyne Therapeutics is USD 1.58B
What is the 1 year trading range for Dyne Therapeutics share price?
Dyne Therapeutics has traded in the range of US$ 14.73 to US$ 47.45 during the past year
What is the PE ratio of Dyne Therapeutics?
The price to earnings ratio of Dyne Therapeutics is -6.7
What is the reporting currency for Dyne Therapeutics?
Dyne Therapeutics reports financial results in USD
What is the latest annual profit for Dyne Therapeutics?
The latest annual profit of Dyne Therapeutics is USD -235.94M
What is the registered address of Dyne Therapeutics?
The registered address for Dyne Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Dyne Therapeutics website address?
The website address for Dyne Therapeutics is www.dyne-tx.com
Which industry sector does Dyne Therapeutics operate in?
Dyne Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
BMRABiomerica Inc
US$ 1.0498
(199.94%)
234.28M
DATSDatChat Inc
US$ 6.4401
(51.18%)
24.95M
WHLRWheeler Real Estate Investment Trust Inc
US$ 3.37
(43.40%)
69.31M
ARQQArqit Quantum Inc
US$ 27.50
(33.56%)
1.32M
DOYUDouYu International Holdings Ltd
US$ 15.80
(28.56%)
1.3M
ATRAAtara Biotherapeutics Inc
US$ 7.14
(-45.74%)
878.96k
LUXHLuxUrban Hotels Inc
US$ 0.3988
(-42.04%)
1.33M
LFLYLeafly Holdings Inc
US$ 0.8399
(-41.67%)
206.19k
SHOTWSafety Shot Inc
US$ 0.1501
(-33.29%)
206
PTLEPTL Ltd
US$ 3.07
(-29.43%)
1.38M
ADTXAditxt Inc
US$ 0.144899
(10.61%)
243.03M
BMRABiomerica Inc
US$ 1.0498
(199.94%)
234.28M
ACONAclarion Inc
US$ 0.0459
(8.00%)
189.77M
RGTIRigetti Computing Inc
US$ 11.079
(1.27%)
102.93M
WHLRWheeler Real Estate Investment Trust Inc
US$ 3.37
(43.40%)
69.31M

最近閲覧した銘柄

Delayed Upgrade Clock